MedTrace Logo

Study of Hemospray for Lower Gastrointestinal Hemorrhage

NCT02099435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-01-20

No results posted yet for this study

Summary

This study is to evaluate the performance of Hemospray for the teatment of nonvariceal lower gastrointestinal bleeding.

Conditions

  • Colonic Diverticula
  • Angiodysplasia
  • Colonic Polyp

Interventions

DEVICE

Hemospray

The Hemospray™ device comes in a 7F kit and a 10F kit. Each kit includes two 220 cm Teflon application catheters, a handle with CO2 cartridge and a syringe containing approximately 20 g of the Hemospray™ material. Hemospray™ is a proprietary inorganic mineral powder that acts as a mechanical barrier when sprayed over a bleeding lesion and the surrounding mucosa.

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-11-06
Completion
2016-11-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099435 on ClinicalTrials.gov